The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

MELTUMP: how to manage these lesions in the clinical routine.

TitleMELTUMP: how to manage these lesions in the clinical routine.
Publication TypeJournal Article
Year of Publication2017
AuthorsPiccolo, V., Moscarella E., Lallas A., Alfano R., Ferrara G., & Argenziano G.
JournalG Ital Dermatol Venereol
Volume152
Issue3
Pagination266-269
Date Published2017 Jun
ISSN1827-1820
KeywordsDecision Trees, Humans, Melanocytes, Melanoma, Prognosis, Skin Neoplasms
Abstract

Although most melanocytic lesions can be diagnosed by histopathologists as benign or malignant with high confidence, a subset of morphologically ambiguous lesions does exist and still represents a significant problem for pathologists. These lesions have been defined as MELTUMP, i.e. melanocytic tumors of uncertain malignant potential. MELTUMP could be considered as a large cauldron in which melanocytic lesions with equivocal morphologic features fall into, including most benign lesions and a minority of melanomas, unfortunately recognizable only a posteriori for their unfavorable outcome. As a consequence of the lack of uniformity in the biologic behavior of melanocytic lesions belonging to the heterogeneous subset of MELTUMP, confusion and lack of agreement in the management of these difficult lesions is increasingly growing up. As most MELTUMP have a favorable prognosis we recommend a conservative approach, avoiding over treatment for this group of lesions.

DOI10.23736/S0392-0488.17.05569-9
Alternate JournalG Ital Dermatol Venereol
PubMed ID28195450

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.